{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:55:46Z","timestamp":1781664946620,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T00:00:00Z","timestamp":1761436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2008715"],"award-info":[{"award-number":["APP2008715"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.vaccine.2025.127912","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:04:23Z","timestamp":1761732263000},"page":"127912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Co-administration of a synthetic saccharide conjugate vaccine with BCG provides synergistic protection against murine tuberculosis"],"prefix":"10.1016","volume":"68","author":[{"given":"Socorro","family":"Miranda-Hernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harindra D.","family":"Sathkumara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kupz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127912_bb0005","author":"WHO"},{"key":"10.1016\/j.vaccine.2025.127912_bb0010","doi-asserted-by":"crossref","first-page":"33577","DOI":"10.1074\/jbc.R110.168328","article-title":"Molecular basis of phosphatidyl-myo-inositol mannoside biosynthesis and regulation in mycobacteria","volume":"285","author":"Guerin","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2025.127912_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/glycob\/5.1.117","article-title":"Structural definition of acylated phosphatidylinositol mannosides from Mycobacterium tuberculosis: definition of a common anchor for lipomannan and lipoarabinomannan","volume":"5","author":"Khoo","year":"1995","journal-title":"Glycobiology"},{"key":"10.1016\/j.vaccine.2025.127912_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1469-0691.2003.00530.x","article-title":"Carbohydrate-protein conjugate vaccines","volume":"9","author":"Ada","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2025.127912_bb0025","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0004-2015","article-title":"Animal models of tuberculosis: an overview","volume":"4","author":"Williams","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.vaccine.2025.127912_bb0030","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127912_bb0035","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fimmu.2019.00532","article-title":"BCG vaccination prevents reactivation of latent lymphatic murine tuberculosis independently of CD4(+) T cells","volume":"10","author":"Sathkumara","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127912_bb0050","article-title":"A modular self-assembling and self-adjuvanting multiepitope peptide nanoparticle vaccine platform to improve the efficacy and immunogenicity of BCG","author":"Zhao","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.vaccine.2025.127912_bb0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chom.2020.10.003","article-title":"Ultra-low dose aerosol infection of mice with Mycobacterium tuberculosis more closely models human tuberculosis","volume":"29","author":"Plumlee","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2025.127912_bb0045","doi-asserted-by":"crossref","first-page":"e1307","DOI":"10.1016\/S2214-109X(22)00283-2","article-title":"Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis","volume":"10","author":"Martinez","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2025.127912_bb0055","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S2213-2600(19)30274-7","article-title":"Insights and challenges in tuberculosis vaccine development","volume":"7","author":"McShane","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2025.127912_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms16085","article-title":"Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis","volume":"8","author":"Aguilo","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.127912_bb0065","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1038\/s41467-021-26934-0","article-title":"A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Gu\u00e9rin","volume":"12","author":"Woodworth","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.127912_bb0070","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.vaccine.2011.11.055","article-title":"Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection","volume":"30","author":"Parlane","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127912_bb0075","doi-asserted-by":"crossref","first-page":"18613","DOI":"10.1038\/s41598-023-45898-3","article-title":"Phosphatidylinositolmannoside vaccination induces lipid-specific Th1-responses and partially protects guinea pigs from Mycobacterium tuberculosis challenge","volume":"13","author":"Eckhardt","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.127912_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2022.900028","article-title":"Immune senescence, immunosenescence and aging","volume":"3","author":"Lee","year":"2022","journal-title":"Front Aging"},{"key":"10.1016\/j.vaccine.2025.127912_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.1059083","article-title":"Effect of puberty on the immune system: relevance to multiple sclerosis","volume":"10","author":"Ucciferri","year":"2022","journal-title":"Front Pediatr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25012095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25012095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:23:40Z","timestamp":1781663020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25012095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":17,"alternative-id":["S0264410X25012095"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127912","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-administration of a synthetic saccharide conjugate vaccine with BCG provides synergistic protection against murine tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127912"}}